ISA Pharmaceuticals is Hiring: Senior Medical Advisor at ISA Pharmaceuticals
You provide medico-scientific support and expertise to the assigned clinical development program and relevant clinical trials. You assist with clinical trial design, set-up, and execution as well as final study report and closure- within GCP requirements. You will be part of a compact clinical research group and we expect you to collaborate well with internal and external partners (CRO’s); you will also liaise with experts and key opinion leaders. You support change management and continuous improvement efforts across programs, identifying and addressing gaps and opportunities.
You are a registered Medical Practitioner in the EU with a minimum of 2-3 years of industry experience, preferably in clinical drug development. You have excellent analytical and interpersonal communication skills and you effectively communicate progress toward milestones, opportunities, and risks to all stakeholders. You have a background in clinical research (preferably oncology) with a working understanding of GCP. You are based in the Benelux and able to work from our offices in Leiden at least part of the time. You are prepared to travel internationally for work.
We offer you a challenging position in a rapidly developing organization and competitive remuneration as well as work/life balance. You will be part of a team of top professionals, and work in an inspiring environment with opportunities for personal and professional growth.
The company culture of ISA is built on four important competences: high quality knowledge, a pragmatic & solution-oriented attitude, we are agile & resilient and appreciate collaboration & learning.
Founded in 2004, ISA Pharmaceuticals is a privately held company based in Leiden, the Netherlands. With a dedicated team of 25 professionals, ISA focuses on the development of immunotherapies for the treatment of cancer and persistent viral infections. ISA’s immunotherapy platform is based on its proprietary SLP® (synthetic long peptide) and AMPLIVANT® technologies. Various clinical trials up to completion of Phase II have demonstrated the safety, tolerability and clinical efficacy of SLP® immunotherapies. Recently, ISA has begun to develop SLP® immunotherapies for serious and chronic infectious diseases. Because of our ongoing expansion we have this job opening for a senior medical advisor.
For further information on this job opening and related career opportunities, please contact Leon Hooftman at firstname.lastname@example.org or +31 71 3322310. We do not appreciate acquisition based on this advertisement.